Cue Biopharma Inc banner

Cue Biopharma Inc
F:1UC

Watchlist Manager
Cue Biopharma Inc Logo
Cue Biopharma Inc
F:1UC
Watchlist
Price: 25.92 EUR 7.82% Market Closed
Market Cap: €1.3B

Wall St Price Targets

1UC Price Targets Summary
Cue Biopharma Inc

Wall Street analysts forecast 1UC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1UC is 2.8 EUR with a low forecast of 2.77 EUR and a high forecast of 2.88 EUR.

Lowest Forecast
Price Target
2.77 EUR
89% Downside
Average Forecast
Price Target
2.8 EUR
89% Downside
Highest Forecast
Price Target
2.88 EUR
89% Downside
Cue Biopharma Inc Competitors:
Price Targets
8961
Mori Trust Sogo Reit Inc
10% Upside
LAND
Gladstone Land Corp
35% Upside
PRQR
ProQR Therapeutics NV
396% Upside

Revenue
Forecast

N/A
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
9%
Average Beat
N/A
Past Growth
26% / Year
Estimated Growth
Estimates Accuracy
9%
Average Beat

The compound annual growth rate for Revenue over the next 3 years is 26%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 1UC's stock price target?
Price Target
2.8 EUR

According to Wall Street analysts, the average 1-year price target for 1UC is 2.8 EUR with a low forecast of 2.77 EUR and a high forecast of 2.88 EUR.

What is the Revenue forecast for Cue Biopharma Inc?
Projected CAGR
26%

The compound annual growth rate for Revenue over the next 3 years is 26%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett